Product NDC: | 54868-4883 |
Proprietary Name: | Moexipril Hydrochloride |
Non Proprietary Name: | Moexipril Hydrochloride |
Active Ingredient(s): | 15 mg/1 & nbsp; Moexipril Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-4883 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078454 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040427 |
Package NDC: | 54868-4883-2 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (54868-4883-2) |
NDC Code | 54868-4883-2 |
Proprietary Name | Moexipril Hydrochloride |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (54868-4883-2) |
Product NDC | 54868-4883 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Moexipril Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20040427 |
Marketing Category Name | ANDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | MOEXIPRIL HYDROCHLORIDE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |